Applied DNA Sciences (NASDAQ:APDN) reported its Q4 earnings results on Thursday, December 7, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Applied DNA Sciences beat estimated earnings by 3.7%, reporting an EPS of $-0.26 versus an estimate of $-0.27.
Revenue was down $2.78 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 10.86% drop in the share price the next day.
Here’s a look at Applied DNA Sciences’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.2 | -0.29 | -0.26 |
| EPS Actual | -0.24 | -0.2 | -0.30 | 0.01 |
| Revenue Estimate | 2.56M | 4.12M | 4.17M | 4.10M |
| Revenue Actual | 2.92M | 4.41M | 5.26M | 3.56M |
To track all earnings releases for Applied DNA Sciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
